The Bottom Line Success on GLP-1 medications isn't just about taking your weekly injectionit's about pairing that medication with a strategic nutrition approach that preserves muscle, minimizes side effects, and sets you up for long-term sustainable weight loss
injection of liraglutide dramatically suppressed the upregulation of CGRP and c-fos in the superficial lamina of the TNC induced by NTG
This dual mechanism is why tirzepatide doses start at 2.5 mg while semaglutide starts at 0.25 mg
Created to combat obesity and diabetes, GLP-1 agonists are now being assessed in dozens of disorders
As per Bradford Hills criteria 41 , the biological plausibility through GLP-1R expression in the nervous system and temporal consistency in time-to-onset analysis support potential causality, but confounding factors inherent to spontaneous reporting systems preclude definitive conclusions
Guidance for 2025 implies an adjusted EBITDA margin of ~12.3% at the midpoint